Israel Englander Cardiol Therapeutics Inc. Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRDL
# of Institutions
45Shares Held
7.22MCall Options Held
5.2KPut Options Held
9.5K-
Tejara Capital LTD London, X03.12MShares$3.8 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD882KShares$1.08 Million0.23% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$970,6620.31% of portfolio
-
Cambridge Investment Research Advisors, Inc.331KShares$403,2160.0% of portfolio
-
Envestnet Asset Management Inc310KShares$377,8140.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $75.6M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...